GP

Gayathiri Ponnusamy

Active Director Director DIN 07585937
DIN 07585937 First appointment Feb 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Feb 2018
Shareholding value •••• Premium profile

About Gayathiri Ponnusamy

Data last updated:

Gayathiri Ponnusamy is a Director at Quantas Bioscience Private Limited (since 2022), Director at Empera Meditech Private Limited (since 2018) and Director at Empera Health Service Private Limited (since 2022), and holds 3 more current directorships. The companies operate in Chemicals, Healthcare and Food and Beverages. The 3 current companies with reported revenue have a combined latest revenue of ₹5.61 Cr; the largest is Quantas Bioscience Private Limited at ₹4.14 Cr (FY 2025). Earlier, Gayathiri Ponnusamy was a Director at Empera Capital Private Limited (2022–2024).

DIN 07585937
Primary Designation Director
Industry Chemicals
First Appointment 06 Feb 2018
Oldest Company Age 8 yrs
Largest company Quantas Bioscience Private Limited · ₹4.14 Cr (FY 2025)
Combined revenue ₹5.61 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Quantas Bioscience Private Limited U24290TZ2022PTC038403
Director09 Mar 20222022₹4.14 Cr (FY 2025)Active
Empera Meditech Private Limited U85310TZ2018PTC029980
Director06 Feb 20182018₹1.32 Cr (FY 2025)Active
Director28 Mar 20222022₹14.3 Lakh (FY 2025)Active
Empera Holdings Private Limited U65990TZ2022PTC038176
Director09 Feb 20222022Active
Director09 Feb 20222022Active
Director25 Sep 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Empera Capital Private Limited U65993TZ2022PTC038351
Director28 Feb 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Gayathiri Ponnusamy

Directorship timeline

Open interactive timeline →
Empera Industries India Private Limited
Quantas Bioscience Private Limited
Empera Health Service Private Limited
Empera Holdings Private Limited
Premium access

Shareholding and investment profile for Gayathiri Ponnusamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gayathiri Ponnusamy

Gayathiri Ponnusamy currently holds 6 directorships: Quantas Bioscience Private Limited (Director, since 09 Mar 2022, revenue ₹4.14 Cr (FY 2025)); Empera Meditech Private Limited (Director, since 06 Feb 2018, revenue ₹1.32 Cr (FY 2025)); Empera Health Service Private Limited (Director, since 28 Mar 2022, revenue ₹14.3 Lakh (FY 2025)); Empera Holdings Private Limited (Director, since 09 Feb 2022); Empera Industries India Private Limited (Director, since 09 Feb 2022); and 1 more.

Gayathiri Ponnusamy was first appointed on 06 Feb 2018 as Director at Empera Meditech Private Limited. The most recent appointment on record is 25 Sep 2025 at Dr Diabetes Advanced Care Private Limited.

The 3 current companies of Gayathiri Ponnusamy that report revenue have a combined latest revenue of ₹5.61 Cr: Quantas Bioscience Private Limited ₹4.14 Cr (FY 2025); Empera Meditech Private Limited ₹1.32 Cr (FY 2025); Empera Health Service Private Limited ₹14.3 Lakh (FY 2025).

Gayathiri Ponnusamy held 1 earlier board appointment: Empera Capital Private Limited (Director, 28 Feb 2022 to 04 Nov 2024).

The current boards of Gayathiri Ponnusamy's companies include Senthil Kumar Muthu Gounder (Quantas Bioscience Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available